Presentation THT Abstracts 2024

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Presenter: Carl Pepine

March 04, 2024

REGISTER for free or LOG IN to view this content

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Heart Failure

Presentation

THT Abstracts 2024

Up Next

Presentation THT Abstracts 2024

Vsling- Ventricular repair device for HFrEF patients

Presenter: Boaz Manash

March 04, 2024

More slides +

Presentation THT Abstracts 2024

The Clinical Effectiveness of Pulmonary Artery Catheter in Patients with Cardiogenic Shock

Presenter: Atsuyuki Watanabe

March 04, 2024

Presentation THT Abstracts 2024

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Presenter: Amish Raval

March 04, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.